These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9418907)

  • 21. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2.
    Murphy KM; Streips UN; Lock RB
    Oncogene; 1999 Oct; 18(44):5991-9. PubMed ID: 10557088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex.
    Medema JP; Scaffidi C; Krammer PH; Peter ME
    J Biol Chem; 1998 Feb; 273(6):3388-93. PubMed ID: 9452459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AML HL-60 cells.
    Ibrado AM; Kim CN; Bhalla K
    Leukemia; 1998 Dec; 12(12):1930-6. PubMed ID: 9844922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L; Yuan J; Stein R
    Oncogene; 2000 Mar; 19(14):1783-93. PubMed ID: 10777212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways.
    Tsujimoto Y; Shimizu S; Eguchi Y; Kamiike W; Matsuda H
    Leukemia; 1997 Apr; 11 Suppl 3():380-2. PubMed ID: 9209397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis.
    Jia L; Macey MG; Yin Y; Newland AC; Kelsey SM
    Blood; 1999 Apr; 93(7):2353-9. PubMed ID: 10090946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria.
    Vander Heiden MG; Chandel NS; Williamson EK; Schumacker PT; Thompson CB
    Cell; 1997 Nov; 91(5):627-37. PubMed ID: 9393856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
    Rashmi R; Kumar S; Karunagaran D
    Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
    Adrain C; Creagh EM; Martin SJ
    EMBO J; 2001 Dec; 20(23):6627-36. PubMed ID: 11726499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3.
    Amarante-Mendes GP; Naekyung Kim C; Liu L; Huang Y; Perkins CL; Green DR; Bhalla K
    Blood; 1998 Mar; 91(5):1700-5. PubMed ID: 9473236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of bcl-xL is relevant to UV-induced apoptosis in fibroblasts.
    Nakagawa Y; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
    J Biochem Mol Biol; 2002 Sep; 35(5):452-8. PubMed ID: 12359085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells.
    Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS
    J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
    Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
    Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
    Kim CN; Wang X; Huang Y; Ibrado AM; Liu L; Fang G; Bhalla K
    Cancer Res; 1997 Aug; 57(15):3115-20. PubMed ID: 9242435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
    Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
    Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-xL inhibits cytochrome c release but not mitochondrial depolarization during the activation of multiple death pathways by tumor necrosis factor-alpha.
    Johnson BW; Cepero E; Boise LH
    J Biol Chem; 2000 Oct; 275(40):31546-53. PubMed ID: 10913120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.
    Deng W; Wang DA; Gosmanova E; Johnson LR; Tigyi G
    Am J Physiol Gastrointest Liver Physiol; 2003 May; 284(5):G821-9. PubMed ID: 12684213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
    Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.